Recent Company News

• 02:48 AM ET Sep 30, 2026
  

  Daito Pharmaceutical, Meiji unit Meiji Seika Pharma, Development Bank of Japan to buy KYORIN Rimedio from KYORIN Pharmaceutical; terms undisclosed (¥1105.0000, 0)

• 03:23 AM ET Sep 16, 2026
  

  Japan August estimated foreign visitor arrivals 3.1M, (9.6%) y/y

• 11:38 PM ET Sep 02, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (79 total)

• 11:07 PM ET Sep 02, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (53 total)

• 11:29 PM ET Aug 31, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (88 total)

• 10:47 PM ET Aug 31, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (76 total)

• 08:23 AM ET Aug 31, 2026
  

  Meiji releases 2026 Integrated Report (0230ET) (¥4491.0000, 0)

• 11:22 PM ET Aug 25, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (43 total)

• 11:14 PM ET Aug 25, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (70 total)

• 03:58 PM ET Aug 25, 2026
  

  Meiji upgraded to overweight from equal-weight at Morgan Stanley (¥4411.0000, 0)